miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1653-1661

  Takeshita, Nobuyoshi ^a   Mori, Mikito ^a   Kano, Masayuki ^a   Hoshino, Isamu ^a   Akutsu, Yasunori ^a   Hanari, Naoyuki ^a   Yoneyama, Yasuo ^a   Ikeda, Norimasa ^a   Isozaki, Yuka ^a   Maruyama, Tetsurou ^a   Akanuma, Naoki ^a   Miyazawa, Yukimasa ^a   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal squamous cell carcinoma; LASP1; microRNA; miR 203

Indexed keywords

LIM AND SH3 PROTEIN; MICRORNA; MICRORNA 203; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL;

3' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; BINDING SITES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM DOMAIN PROTEINS; MICRORNAS; TRANSFECTION;

EID: 84867759135     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1614     Document Type: Article

References (40)

1. Chen J, Pan J, Zheng X, et al: Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82: 475-482, 2012.
2. Yuequan J, Shifeng C and Bing Z: Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery. Ann Thorac Surg 90: 908-913, 2010.
3. Altorki N, Kent M, Ferrara C and Port J: Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236: 177-183, 2002. (Pubitemid 34809536)
4. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359: 1727-1733, 2002.
5. Blamey RW, Hornmark-Stenstam B, Ball G, et al: ONCOPOOL - a European database for 16,944 cases of breast cancer. Eur J Cancer 46: 56-71, 2010.
6. Morris EJ, Sandin F, Lambert PC, et al: A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 60: 1087-1093, 2011.
7. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
9. He L and Hannon GJ: MicroRNAs: small RNAs with a big role gene regulation. Nat Rev Genet 5: 522-531, 2004. (Pubitemid 38868508)
10. Schickel R, Boyerinas B, Park SM and Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974, 2008.
11. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005. (Pubitemid 40839734)
12. Calin GA, Trapasso F, Shimizu M, et al: Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 352: 1667-1676, 2005. (Pubitemid 40530233)
13. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
14. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
15. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
16. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
17. Feber A, Xi L, Luketich JD, et al: MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135: 255-260, 2008.
18. Guo Y, Chen Z, Zhang L, et al: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68: 26-33, 2008. (Pubitemid 351380102)
19. Hiyoshi Y, Kamohara H, Karashima R, et al: MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15: 1915-1922, 2009.
20. Kano M, Seki N, Kikkawa N, et al: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
21. Tomasetto C, Regnier C, Moog-Lutz C, et al: Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-21.3 region of chromosome 17. Genomics 28: 367-376, 1995.
22. Zhao L, Wang H, Liu C, et al: Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 59: 1226-1235, 2010.
23. Takahashi K, Kanazawa H, Chan CT, Hosono T, Takahara M and Sato K: A case of esophageal carcinoma metastatic to the mandible and characterization of 2 cell lines (T.T and T. Tn) established from the oral tumor. Jpn J Oral Maxillofac Surg 36: 67-76, 1990.
24. Nishihira T, Kasai M, Mori S, et al: Characteristics of 2 cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann 70: 575-584, 1979. (Pubitemid 10139660)
25. Yi R, Poy MN, Stoffel M and Fuchs E: A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452: 225-229, 2008. (Pubitemid 351380241)
26. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, et al: miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ 15: 1187-1195, 2008. (Pubitemid 351850972)
27. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, et al: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506, 2008. (Pubitemid 351763902)
28. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776, 2010.
29. Yuan Y, Zeng ZY, Liu XH, et al: MicroRNA-203 inhibits cell proliferation by repressing. Np63 expression in human esophageal squamous cell carcinoma. BMC Cancer 11: 57, 2011.
30. Bo J, Yang G, Huo K, et al: microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278: 786-792, 2011.
31. Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, et al: Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 223: 72-80, 2011.
32. Saini S, Majid S, Yamamura S, et al: Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin Cancer Res 17: 5287-5298, 2010.
33. Chen HY, Han ZB, Fan JW, et al: miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver. Med Oncol: Jul 24, 2011 (Epub ahead of print).
34. Chew CS, Chen X, Parente JA Jr, Tarrer S, Okamoto C and Qin HY: Lasp-1 binds to non-muscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo. J Cell Sci 115: 4787-4799, 2002. (Pubitemid 36054632)
35. Lin YH, Park ZY, Lin D, et al: Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J Cell Biol 165: 421-432, 2004. (Pubitemid 38649916)
36. Chiyomaru T, Enokida H, Kawakami K, et al: Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 30: 434-443, 2012.
37. Viticchiè G, Lena AM, Latina A, et al: miR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 10: 1121-1131, 2011.
38. Sadanandam A, Varney ML, Singh S, et al: High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. Int J Cancer 127: 1373-1383, 2010.
39. Choi SY, Jang JH and Kim KR: Analysis of differentially expressed genes in human rectal carcinoma using suppression subtractive hybridization. Clin Exp Med 11: 219-226, 2011.
40. Song K, Li Q, Peng YB, et al: Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling. Biochem J 436: 271-282, 2011.